treosulfan "medac" 1 g pulver til infusionsvæske, opløsning
medac gesellschaft für klinische - treosulfan - pulver til infusionsvæske, opløsning - 1 g
treosulfan "medac" 5 g pulver til infusionsvæske, opløsning
medac gesellschaft für klinische - treosulfan - pulver til infusionsvæske, opløsning - 5 g
treosulfan "medac" 250 mg kapsler, hårde
medac, gesellschaft für klinische spezialpräparate mbh - treosulfan - kapsler, hårde - 250 mg
trecondi
medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoietisk stamcelletransplantation - antineoplastiske midler - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
treosulfan "tillomed" 5 g pulver til infusionsvæske, opløsning
tillomed pharma gmbh - treosulfan - pulver til infusionsvæske, opløsning - 5 g
tepadina
adienne s.r.l. s.u. - thiotepa - hematopoietisk stamcelletransplantation - antineoplastiske midler - i kombination med andre kemoterapeutiske lægemidler:med eller uden total body bestråling (tbi) som konditionering behandling forud for allogen eller autolog hæmatopoietisk stamcelletransplantation (hpct) hæmatologiske sygdomme hos voksne og pædiatriske patienter, når høj-dosis kemoterapi med hpct support er passende til behandling af solide tumorer hos voksne og pædiatriske patienter. det foreslås, at tepadina skal ordineres af læger med erfaring i plejende behandling forud for hæmatopoietisk stamcelletransplantation.
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
thiodan flydende middel
hoechst schering agrevo as - endosulfan - flydende middel - 350 g/l endosulfan
thiodan emulsion flydende middel
hoechst schering agrevo as - endosulfan - flydende middel - 355 g/l endosulfan
marshal tech. flydende middel
cillus a/s - carbosulfan - flydende middel - 900 g/l carbosulfan